101. New variants in Spanish Niemann-Pick type c disease patients.
- Author
-
López de Frutos L, Cebolla JJ, Aldámiz-Echevarría L, de la Vega Á, Stanescu S, Lahoz C, Irún P, and Giraldo P
- Subjects
- Alleles, Biomarkers, Child, Child, Preschool, Computational Biology methods, DNA Mutational Analysis, Databases, Genetic, Female, Humans, Infant, Intracellular Signaling Peptides and Proteins genetics, Male, Mutation, Niemann-Pick C1 Protein, Niemann-Pick Disease, Type C metabolism, Severity of Illness Index, Spain, Genetic Association Studies methods, Genetic Predisposition to Disease, Genetic Variation, Niemann-Pick Disease, Type C diagnosis, Niemann-Pick Disease, Type C genetics
- Abstract
Niemann-Pick type C (NPC) disease is a rare inherited disease, with progressive neurodegeneration as the main symptom. It is a lysosomal storage disorder caused by mutations in NPC1 or NPC2 genes, leading to a lysosomal cholesterol trafficking impairment. Disease indicators are the clinical suspicion and biomarker levels. However, a genetic study is mandatory for the diagnosis, which is complicated due to the different variants with unknown significance. The aim of this work was to identify the variants responsible for NPC in our pediatric population. Twenty-two samples from non-related infants believed to have NPC disease were analyzed during the last 3 years. Surrogate biomarkers of the disease were evaluated whenever possible. Sanger sequencing for both genes is reported for all samples. Complementary genetic studies were performed when necessary. NPC disease was confirmed in 31.8% of subjects due to homozygous or compound heterozygous genetic variants in NPC1. The following four novel variants were identified: a gross deletion variant composed of the gene promoter and the first exon, NM_000271.3:c.385delT, NM_000271.3:c.1553+1342_1655-291del, and NM_000271.3:c.1757delA. None had functional activity and all resulted in important structural changes in the protein.
- Published
- 2020
- Full Text
- View/download PDF